108 related articles for article (PubMed ID: 17620507)
1. Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease.
Kiechl S; Schett G; Schwaiger J; Seppi K; Eder P; Egger G; Santer P; Mayr A; Xu Q; Willeit J
Circulation; 2007 Jul; 116(4):385-91. PubMed ID: 17620507
[TBL] [Abstract][Full Text] [Related]
2. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
Sandberg WJ; Yndestad A; Øie E; Smith C; Ueland T; Ovchinnikova O; Robertson AK; Müller F; Semb AG; Scholz H; Andreassen AK; Gullestad L; Damås JK; Frøland SS; Hansson GK; Halvorsen B; Aukrust P
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):857-63. PubMed ID: 16424351
[TBL] [Abstract][Full Text] [Related]
3. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
4. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
Kiechl S; Werner P; Knoflach M; Furtner M; Willeit J; Schett G
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):801-11. PubMed ID: 17173497
[TBL] [Abstract][Full Text] [Related]
5. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
7. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events.
de Kleijn DP; Moll FL; Hellings WE; Ozsarlak-Sozer G; de Bruin P; Doevendans PA; Vink A; Catanzariti LM; Schoneveld AH; Algra A; Daemen MJ; Biessen EA; de Jager W; Zhang H; de Vries JP; Falk E; Lim SK; van der Spek PJ; Sze SK; Pasterkamp G
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):612-9. PubMed ID: 20018935
[TBL] [Abstract][Full Text] [Related]
8. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
9. Relationship of sRANKL level and vascular calcification score to cardiovascular events in maintenance hemodialysis patients.
Wei T; Wang M; Wang M; Gan LY; Li X
Blood Purif; 2009; 28(4):342-5. PubMed ID: 19729902
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of receptor activator of nuclear factor kappaB ligand (RANKL) in healthy women and men.
Kerschan-Schindl K; Wendlova J; Kudlacek S; Gleiss A; Woloszczuk W; Pietschmann P
Exp Clin Endocrinol Diabetes; 2008 Aug; 116(8):491-5. PubMed ID: 18072013
[TBL] [Abstract][Full Text] [Related]
11. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?
Spelling P; Bonfá E; Caparbo VF; Pereira RM
Scand J Rheumatol; 2008; 37(6):439-44. PubMed ID: 18802807
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
15. Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling.
Quercioli A; Montecucco F; Bertolotto M; Ottonello L; Pende A; Mach F; Dallegri F
Eur J Clin Invest; 2010 Jul; 40(7):645-54. PubMed ID: 20497460
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.
Quercioli A; Mach F; Bertolotto M; Lenglet S; Vuilleumier N; Galan K; Pagano S; Braunersreuther V; Pelli G; Pistoia V; Bianchi G; Cittadini G; Viviani GL; Pende A; Roux-Lombard P; Thomas A; Staub C; Ratib O; Dallegri F; Schindler TH; Montecucco F
Thromb Haemost; 2012 Jan; 107(1):124-39. PubMed ID: 22116393
[TBL] [Abstract][Full Text] [Related]
17. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
[TBL] [Abstract][Full Text] [Related]
18. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
Hamer M; Chida Y; Stamatakis E
Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
[TBL] [Abstract][Full Text] [Related]
20. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
